Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emlucast FX 10 mg/120 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Montelukast is a leukotriene antagonist. It works by blocking the action of a chemical messenger (leukotriene). This reduces inflammation (swelling) in the airways and nose, and improves symptoms. Fexofenadine is an antiallergic which blocks the action another chemical messenger (histamine) responsible for runny nose, watery eyes and sneezing.
Emlucast FX 10 mg/120 mg Tablet may cause excessive drowsiness and calmness with alcohol.
WEIGH RISKS VS BENEFITS
Emlucast FX 10 mg/120 mg Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Emlucast FX 10 mg/120 mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Emlucast FX 10 mg/120 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Emlucast FX 10 mg/120 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emlucast FX 10 mg/120 mg Tablet may be needed. Please consult your doctor. May cause excessive sleepiness in patients with end stage kidney disease.
Emlucast FX 10 mg/120 mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Emlucast FX 10 mg/120 mg Tablet may not be needed in these patients. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Emlucast FX 10 mg/120 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 18th Apr 2017.